Skip to content

Dimethyl fumarate

Tecfidera, Skilarence (dimethyl fumarate) is a small molecule pharmaceutical. Dimethyl fumarate was first approved as Tecfidera on 2013-03-27. It has been approved in Europe to treat multiple sclerosis and psoriasis. Tecfidera's patents are valid until 2035-11-16 (FDA).
Trade Name Skilarence, Tecfidera
Common Name Dimethyl fumarate
Indication multiple sclerosis, psoriasis
Drug Class
Dimethyl fumarate
Get full access now